Patricia Sousa, et al. Preclinical development of EDIT-301, an autologous cell therapy comprising AsCas12a-RNP-modified mobilized peripheral blood CD34+ cells for the potential treatment of transfusion-dependent beta thalassemia. Presented at The 63rd Annual Meeting and Exposition of the American Society of Hematology. December 11-14, 2021.